1. Home
  2. AAOI vs ARWR Comparison

AAOI vs ARWR Comparison

Compare AAOI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Applied Optoelectronics Inc.

AAOI

Applied Optoelectronics Inc.

HOLD

Current Price

$106.60

Market Cap

14.8B

Sector

Technology

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$85.30

Market Cap

12.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAOI
ARWR
Founded
1997
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
12.4B
IPO Year
2013
2009

Fundamental Metrics

Financial Performance
Metric
AAOI
ARWR
Price
$106.60
$85.30
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$66.80
$83.40
AVG Volume (30 Days)
11.2M
1.1M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
85.78
99.80
EPS
N/A
N/A
Revenue
N/A
$16,142,321.00
Revenue This Year
$119.87
N/A
Revenue Next Year
$129.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.50
$22.73
52 Week High
$233.67
$95.49

Technical Indicators

Market Signals
Indicator
AAOI
ARWR
Relative Strength Index (RSI) 43.82 48.61
Support Level $82.67 $82.70
Resistance Level $125.35 $87.83
Average True Range (ATR) 11.96 2.65
MACD -2.34 -0.40
Stochastic Oscillator 12.63 26.08

Price Performance

Historical Comparison
AAOI
ARWR

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products, for four networking end-markets; internet data center, CATV, telecom, and FTTH. The Company designs and manufactures a wide range of optical communications products at varying levels of integration, from components, subassemblies, and modules to meet turn-key equipment. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The Company has manufacturing and research and development facilities located in the U.S., Taiwan, and China.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: